Obesity-related and diabetes-related metabolic disorders, such as impaired insulin sensitivity and non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH), contribute to increasing the incidence of HCC with a non-viral etiology [14]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.